The internet overwhelms parents of cancer patients
The internet might be the great icon of the information age, but when it comes to parents learning about the cancers of their children, parents overwhelmingly prefer speaking with a trusted health professional.
According to findings published in the most recent issue of Sociology of Health and Illness and carried out by researchers from Roswell Park Cancer Institute, parents of children with cancer:
-- find themselves in over their heads with all the information offered up on the internet.
-- uncertain about who to trust, a situation that creates anxiety
-- fearful of finding similar cases and reading about negative, worst-case scenarios.
The study was titled "The Devil You Know: Parental Online Information Seeking after a Pediatric Cancer Diagnosis."
Source: CancerTreatment.net
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
